Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that responds to a wide range of chemicals, including chemical carcinogens such as dioxins and carcinogenic polyaromatic hydrocarbons, and induces a battery of genes associated with detoxification, proliferation, and immu...
Main Authors: | Takanori Hidaka, Taku Fujimura, Setsuya Aiba |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00194/full |
Similar Items
-
An Increased Level of Aryl Hydrocarbon Receptor in Patients with Pancreatic Cancer
by: Sahar Masoudi, et al.
Published: (2019-01-01) -
Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside
by: Taku Fujimura, et al.
Published: (2019-09-01) -
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma
by: Yota Sato, et al.
Published: (2020-10-01) -
Modulation of Immune Responses by Nutritional Ligands of Aryl Hydrocarbon Receptor
by: Alba De Juan, et al.
Published: (2021-05-01) -
The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors
by: Maria L. Perepechaeva, et al.
Published: (2020-04-01)